Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Sensipar® (cinacalcet) Tablets
Medication labelWhy this: Advisory · dailymed-prescription
Sensipar® is indicated for the treatment of secondary hyperparathyroidism in patients with Chronic Kidney Disease on dialysis. Sensipar® is indicated for the treatment of hypercalcemia in patients with parathyroid carcinoma.
- generic_name
- cinacalcet hydrochloride
- product_names
- cinacalcet hydrochloride
- ndc
- 53808-0577, 55513-073, 53808-0577-1, 53808-0578, 55513-074, 53808-0578-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en